Search Results

Site Search

MCL Coagulation Test Request Form T753 MC076704A

MCL Coagulation Test Request Form T753 Complete print Reset Form Coagulation Test Request Client Information required Client Patient Information required Patient ID Medical Record

https://news.mayocliniclabs.com/mc2775-782/

N N E C T I N G Pharma and biotech TABLE OF CONTENTS What makes a good testing partner? Case study 1 Gastrointestinal study collects and tests patient specimens at......

Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights

inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size...

Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights

administered in recurrent GBM patients either at the resection cavity (Group A), or, intratumorally on day 1, followed by a second dose administered in the resection cavity after tumor resection on day 5 (Group...

autoimmune-paraneoplastic-myelopathy-evaluation-algorithm-serum.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Myelopathy Evaluation Algorithm-Serum ■ TRIM46 antibody by CBA ■ TRIM46 antibody by IF titer assay ■ Amphiphysin...

MCL Hereditary Dyslipidemia Patient Information MC1235295

MCL Hereditary Dyslipidemia Patient Information Complete print Reset Form Hereditary Dyslipidemia Patient Information Instructions Accurate interpretation reporting genetic results contingent

International System of Units (SI) Conversion - Mayo Clinic Laboratories

Convert conventional units of measure to SI units.

autoimmune-paraneoplastic-movement-disorder-evaluation-algorithm-serum.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Movement Disorder Evaluation Algorithm – Serum ■ GFAP alpha subunit antibody by CBA ■ GFAP alpha subunit antibody by...

newborn-screen-elevated-c0-c16-c18.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/20/23 Newborn screen results: ■ Elevated or normal free carnitine (C0) ■ Elevated C0/C16+C18 ratio Perform: Plasma ammonia, blood gas, glucose,...

MCL Combined Immunodeficiency Severe Combined Immunodeficiency and BCellAntibody Deficiency Patient Information MC1235309

MCL Combined Immunodeficiency Severe Combined Immunodeficiency BCellAntibody Deficiency Patient Information Complete print Reset Form Combined Immunodeficiency Severe Combined Immunodeficiency Cell Antibody Deficiency Patient Information...

Units of Measurement - Mayo Clinic Laboratories

Units of Measure A list of common units used in the reporting of our assays has been defined. Refer to the table for these units as well as the recommended report abbreviations. Last updated: February 27, 2024...

vitamin_b12_deficiency_evaluation.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 03/2022 Vitamin B12 Deficiency Evaluation <150 ng/L>400 ng/L 150-400 ng/L ≤0.4 nmol/mL >0.4 nmol/mL INDETERMINATE ACASM / Pernicious Anemia Cascade,...

Pleural Mesothelioma - Insights

In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.

MCL - Blood Spot Collection Instructions (Spanish) - Brochure - MC4091-67SP

MCL - Blood Spot Collection Instructions (Spanish) - Brochure

Test Classification Updates - Mayo Clinic Laboratories

Share Print Web: mayocliniclabs.com...

New tests launched in May - Insights

In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Mayo Clinic Laboratories Critical Values / Critical Results List

Mayo Clinic Laboratories Critical Values / Critical Results List DEFINITION A Critical Value / Critical Result is defined as: A value/result that represents a pathophysiological state at such variance with normal (expected values) as...

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator - Insights

For guidance on when to use the calculator, please see the following algorithm: Acquired Neuropathy Diagnostic Algorithm.

https://www.mayocliniclabs.com/-/media/mediax/customer-service/mayoaccess/ma-workstation-setup-guide.pdf?sc_lang=en&hash=80F7F54389FE5FFAE754B5711FC4EF75

MayoACCESS® Workstation Setup Guide Page 2 4/28/25 MayoACCESS Workstation Setup Guide TABLE OF CONTENTS Introduction...

Test Catalog - Mayo Clinic Laboratories

A B C D E F G H I J K L M N O...

Whole exome sequencing for hereditary disorders - Insights

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...

https://news.mayocliniclabs.com/file-mfa-user-guide/

Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 10/10/2023 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...

Applying the Staffing-to-Workload Methodology: Same-Day Testing Staffing Model - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses how to apply the staffing-to-workload methodology to accommodate same-day testing requirements.

New Tests - Mayo Clinic Laboratories

Share Print Web: mayocliniclabs.com...

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

https://www.mayocliniclabs.com/-/media/it-mmfiles/Special-Instructions/6/6/D/Multi-Factor-Authentication-User-Guide.pdf

Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 6/27/2024 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction...

New Tests Launched in February - Insights

In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Calprotectin and Inflammatory Bowel Disease - Insights

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...

IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights

In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.

Large Scale Study: Outcomes for Long QT Syndrome Patients Treated at Specialty Center Are Better - Insights

Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...

Pathways Case Studies: April 2021 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Genitourinary Pathology,...

CPT codes and LOINC update: December 2024 - Insights

This will be the last CPT Codes and LOINC update. Read why.

Precision mental and behavioral health therapeutics - Insights

Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.

MCLRequest for Supplies MC0748

MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...

Multiplex PCR for Microbial Detection in Spinal Fluid (BIOFIRE FILMARRAY Meningitis/Encephalitis Panel) - Insights

In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.

New tests launched in March - Insights

In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

VEXAS syndrome - Insights

Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.

TPNUQ genotyping assay - Insights

Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which...

Emergency/Overdose - Mayo Clinic Laboratories

Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...

https://www.mayocliniclabs.com/test-catalog/pdf-reports.php

MCL PDF Reports Values current as of June 5, 2025 Mayo Test ID Published Name PDF 2OHGP 2-Hydroxyglutaric Aciduria Gene Panel, Varies Supplemental 3MGAP 3-Methylglutaconic Aciduria Panel, Varies Supplemental ADPKP Focused Autosomal...

Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.

COVID-19 weekly news: April 4-10 2022 - Insights

Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.

Mayo Clinic Laboratory and Pathology Research Roundup: November 7, 2023 - Insights

This week's research roundup feature: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence...